Belgium

 

New AI act could stifle EU innovation – but benefit the UK

After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.
December 15, 2023

EDG sale predicted for Q1 2024

Multiple sources tell HBI that Nordic Capital-owned multinational European Dental Group (EDG) will be back on the market in Q1 ’24. HBI also hears Mehilainen could be back in the shop window soon too.
November 17, 2023

Clariane to sell €1bn of assets and possibly exit Belgium and The Netherlands

Pan-European French elderly care giant Clariane (formerly Korian) plans to sell over €1bn worth of assets to help shore up its finances and get its debt-to-equity leverage ratio under 3x by 2025. Its Belgian and Dutch nursing homes are top of the list of potential assets to sell. A real estate investor with close connections to the company tells us this will involve the sale of the opco as well as the propco, but a Clariane spokesperson declined to confirm this for us.
November 17, 2023

Belgian crackdown after Orpea’s French folly

Outside France, nursing home group Orpea has largely escaped scrutiny in the countries it operates in following its well publicised difficulties, except in its French-speaking neighbour - Belgium. HBI catches up with two operators in the region to hear what the knock-on reputational impact has been like for Belgian businesses.
October 13, 2023

iCON buys Alliance Medical

The longstanding bidding war for pan-European diagnostic firm Alliance Medical Group is over, with iCON Infrastructure confirmed as the new buyer. The £910m deal ends months of speculation. HBI asks a UK-based consultant what this means for the market.
October 13, 2023

Alliance Medical sale “imminent”

HBI hears that the longstanding sale of UK diagnostic firm Alliance Medical Group is imminent, with two bidders left in the process and pan-European operator Affidea tipped to be the front-runner. We speak to three market experts to find out more about the deal which is being valued at around $800m-$1bn.
September 22, 2023

Orpea likely looking to sell in Belgium

Orpea Belgium’s 2022 results are public, and it doesn’t look good. Having suffered a historic loss approaching €400 million last year and with Orpea looking to sell its non core business, we ask a market expert whether and when divestment there looks likely.
August 25, 2023
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us